Intelligence · Clinical Pipeline
HALOZYME THERAPEUTICS Pipeline
All ClinicalTrials.gov programs at HALOZYME THERAPEUTICS — phase, modality, and trial IDs.
- Programs
- 11
Quick answer
HALOZYME THERAPEUTICS has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Commercial Hylenex® recombinant (hyaluronidase human injection)
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Hylenex
HALOZYME THERAPEUTICS, INC.
Healthy
2 trials -
Isotonic hydration fluid and recombinant human hyaluronidase
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
Rapid Acting insulin with pre-treatment of rHuPH20
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Sham Injection
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Subcutaneous HYLENEX (recombinant human hyaluronidase) and Lactated Ringer's solution
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
hyaluronidase (human recombinant)/rehydration fluid
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
hylenex-facilitated subcutaneous Lactated Ringer's infusion
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
large protein molecule
HALOZYME THERAPEUTICS, INC.
Rheumatoid Arthritis
1 trial -
recombinant human hyaluronidase
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
recombinant human hyaluronidase
HALOZYME THERAPEUTICS, INC.
Healthy
1 trial
Frequently asked questions
How many pipeline programs does HALOZYME THERAPEUTICS have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs